155 related articles for article (PubMed ID: 31646448)
1. Defining and Refining the Role for Surgery and Intraperitoneal Chemotherapy in the Treatment of Peritoneal Surface Malignancies.
Choudry MH; Bartlett DL; Alexander HR; Turaga KK
Ann Surg Oncol; 2020 Jan; 27(1):73-75. PubMed ID: 31646448
[No Abstract] [Full Text] [Related]
2. Is There a Role for Intraperitoneal Chemotherapy, Including HIPEC, in the Management of Ovarian Cancer?
Vergote I; Harter P; Chiva L
J Clin Oncol; 2019 Sep; 37(27):2420-2423. PubMed ID: 31403870
[No Abstract] [Full Text] [Related]
3. Peritoneal carcinomatosis from ovarian carcinoma treated by interval laparoscopic complete cytoreduction and HIPEC with extraction through natural orifice.
Arjona-Sánchez Á; Durán M; Sánchez-Hidalgo JM; Rufian-Peña S
Surg Oncol; 2019 Dec; 31():14-15. PubMed ID: 31472328
[No Abstract] [Full Text] [Related]
4. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: from novelty to routine in selected cases.
Moran BJ
Tech Coloproctol; 2017 Sep; 21(9):767-769. PubMed ID: 28936563
[No Abstract] [Full Text] [Related]
5. Cytoreductive surgery and HIPEC in the treatment of peritoneal metastases of sarcomas and other rare malignancies.
Olesiński T
Pol Przegl Chir; 2017 Dec; 89(6):31-36. PubMed ID: 29335392
[TBL] [Abstract][Full Text] [Related]
6. Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.
Canda AE; Arslan C; Terzi C; Sokmen S; Yavuzsen T; Ozkardesler S; Unlu M; Obuz F; Fuzun M
World J Surg Oncol; 2018 Mar; 16(1):70. PubMed ID: 29587771
[TBL] [Abstract][Full Text] [Related]
7. Current practices and future steps for hyperthermic intraperitoneal chemotherapy.
Fields AC; Lu PW; Li GZ; Welten V; Jolissaint JS; Vierra BM; Saadat LV; Larson AC; Atkinson RB; Melnitchouk N
Curr Probl Surg; 2020 Mar; 57(3):100727. PubMed ID: 32151327
[No Abstract] [Full Text] [Related]
8. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases of colorectal origin.
Kok NF; de Hingh IH
Br J Surg; 2017 Mar; 104(4):313-315. PubMed ID: 28112791
[No Abstract] [Full Text] [Related]
9. Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC Trial.
Glockzin G; Zeman F; Croner RS; Königsrainer A; Pelz J; Ströhlein MA; Rau B; Arnold D; Koller M; Schlitt HJ; Piso P
Clin Colorectal Cancer; 2018 Dec; 17(4):285-296. PubMed ID: 30131226
[TBL] [Abstract][Full Text] [Related]
10. ASO Author Reflections: Impact of Operative Technique on Anastomotic Failure During Cytoreductive Surgery for Peritoneal Malignancies-Surgeon Preference is Fine.
Wiseman JT; Cloyd JM
Ann Surg Oncol; 2020 Mar; 27(3):793-794. PubMed ID: 31691109
[No Abstract] [Full Text] [Related]
11. Techniques for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
Dodson RM; Kuncewitch M; Votanopoulos KI; Shen P; Levine EA
Ann Surg Oncol; 2018 Aug; 25(8):2152-2158. PubMed ID: 29388121
[No Abstract] [Full Text] [Related]
12. Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options.
Vassos N; Piso P
Curr Treat Options Oncol; 2018 Sep; 19(10):49. PubMed ID: 30173342
[TBL] [Abstract][Full Text] [Related]
13. [Diffuse malignant peritoneal mesothelioma (DMPM) - a rare diagnosis].
Habbel VSA; Mahler EA; Feyerabend B; Oldhafer KJ; Lipp MJ
Z Gastroenterol; 2020 Feb; 58(2):146-151. PubMed ID: 32050285
[TBL] [Abstract][Full Text] [Related]
14. ASO Author Reflections: What is the Best Therapeutic Strategy for Patients with Limited Synchronous Peritoneal Metastases of Colorectal Cancer?
Mariani A; Goere D
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):818. PubMed ID: 31667730
[No Abstract] [Full Text] [Related]
15. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer.
Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M
Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829
[TBL] [Abstract][Full Text] [Related]
16. Treatment of peritoneal carcinomatosis with hyperthermic intraperitoneal chemotherapy in colorectal cancer.
Behrenbruch C; Hollande F; Thomson B; Michael M; Warrier SK; Lynch C; Heriot A
ANZ J Surg; 2017 Sep; 87(9):665-670. PubMed ID: 28664645
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal Surface Disease Severity Score (PSDSS), AGO-score and TIAN model in patients with platinum-sensitive recurrent ovarian cancer treated by cytoreductive surgery plus HIPEC.
Gómez-Ruiz ÁJ; González-Gil A; Gil J; Navarro-Barrios Á; Alconchel F; Gil E; Martínez J; Nieto A; Barceló F; Cascales-Campos PA
Clin Exp Metastasis; 2019 Oct; 36(5):433-439. PubMed ID: 31270731
[TBL] [Abstract][Full Text] [Related]
18. American Society of Peritoneal Surface Malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer.
Esquivel J; Piso P; Verwaal V; Bachleitner-Hofmann T; Glehen O; González-Moreno S; Deraco M; Pelz J; Alexander R; Glockzin G
J Surg Oncol; 2014 Dec; 110(7):777-8. PubMed ID: 25043759
[No Abstract] [Full Text] [Related]
19. Long-term Quality of Life After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei: A Prospective Longitudinal Study.
Stearns AT; Malcomson L; Punnett G; Abudeeb H; Aziz O; Selvasekar CR; Fulford PE; Wilson MS; Renehan AG; O'Dwyer ST
Ann Surg Oncol; 2018 Apr; 25(4):965-973. PubMed ID: 29313146
[TBL] [Abstract][Full Text] [Related]
20. The Utility of Diagnostic Laparoscopy in Patients Being Evaluated for Cytoreductive Surgery and Hyperthermic Peritoneal Chemotherapy.
Bravo R; Jafari MD; Pigazzi A
Am J Clin Oncol; 2018 Dec; 41(12):1231-1234. PubMed ID: 29782364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
